Our Pricing

Understanding Wegovy 1mg: Maintenance Dosing for Weight Loss

Finding a reliable wegovy 1mg pen UK online pharmacy with transparent pricing and clinical support is essential when you reach maintenance dosing. At Cured Pharmacy, the Wegovy 1mg pen is available from £79.00, dispensed following a free online consultation with UK-registered prescribers, ensuring safe progression through your weight management programme.

What Is the Wegovy 1mg Pen and When Is It Used?

The Wegovy 1mg pen represents the fourth dose level in the semaglutide dose escalation schedule, typically prescribed after patients have completed the 0.25mg, 0.5mg, and 0.75mg stages [1]. This graduated approach, recommended by the MHRA and supported by the STEP clinical trial programme, allows your body to adapt to semaglutide whilst minimising gastrointestinal side effects.

Semaglutide, the active ingredient in Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics natural hormones regulating appetite and blood sugar [1]. In the STEP 1 trial, participants achieved an average weight reduction of 14.9% over 68 weeks when combined with lifestyle intervention [2]. The 1mg dose serves as a transitional step before reaching the full 2.4mg maintenance dose, ensuring clinical efficacy whilst supporting tolerability.

How Wegovy 1mg Fits Into Your Weight Loss Journey

Wegovy follows a structured five-step dose escalation protocol designed by Novo Nordisk and validated through extensive clinical trials [1]. You begin at 0.25mg weekly for four weeks, progress to 0.5mg for another four weeks, then 1mg, followed by 1.7mg, before reaching the target maintenance dose of 2.4mg. Each pen contains four pre-filled doses administered via subcutaneous injection once weekly.

The 1mg stage typically begins at week 9 of treatment, allowing your body four weeks to adjust before moving to 1.7mg. This careful titration schedule reduces the likelihood of nausea, vomiting, and diarrhoea—the most commonly reported side effects in clinical trials [2]. Your UK prescriber will monitor your progress throughout, adjusting the timeline if you experience persistent adverse effects or require additional time at each dose level.

Why Dose Escalation Matters

Abrupt increases in GLP-1 receptor agonist doses can trigger significant gastrointestinal distress, potentially leading to treatment discontinuation [2]. The graduated approach used with Wegovy allows your digestive system to adapt to semaglutide's effects on gastric emptying and satiety signalling. Clinical data from the STEP trials demonstrated that patients following the prescribed escalation schedule had significantly lower discontinuation rates compared to those attempting faster dose increases.

Wegovy 1mg Pen UK Online Pharmacy: What to Expect

When ordering through a UK-registered online pharmacy like Cured Pharmacy (GPhC 9012511), you'll complete a clinical assessment reviewed by qualified UK prescribers before any medication is dispensed. This consultation typically takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [3].

Following prescriber approval, your Wegovy 1mg pen is dispensed from our UK-licensed pharmacy and delivered in discreet packaging. Each pen contains four 1mg doses, providing one month of treatment when administered weekly as directed. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all dispensing processes, ensuring genuine UK-licensed medicines reach patients safely and efficiently.

Transparent Pricing Before Consultation

Unlike some services that reveal costs only after consultation, Cured Pharmacy displays upfront pricing before you begin your assessment. The Wegovy 1mg pen is available from £79.00, representing competitive UK pricing with our lowest price guarantee. This transparency allows you to make informed decisions about your weight management programme without unexpected costs.

Clinical Evidence Supporting Wegovy at 1mg and Beyond

The STEP clinical trial programme enrolled over 4,500 participants across five major studies, establishing semaglutide 2.4mg as the most effective GLP-1 treatment for weight management licensed in the UK [2]. Whilst the 1mg dose is not the final maintenance level, it plays a crucial role in the escalation pathway that enables patients to reach and tolerate the full therapeutic dose.

STEP 1, the pivotal trial, demonstrated that 68 weeks of semaglutide 2.4mg produced average weight loss of 14.9% compared to 2.4% with placebo, both combined with lifestyle intervention [2]. Importantly, 86.4% of participants on semaglutide achieved at least 5% weight loss, and 69.1% achieved at least 10% weight loss—thresholds associated with meaningful improvements in cardiovascular risk factors and metabolic health [4]. These outcomes depend on completing the full dose escalation schedule, including the 1mg stage.

Managing Side Effects During the 1mg Dose Phase

Gastrointestinal side effects—particularly nausea, diarrhoea, vomiting, and constipation—are most common during dose escalation phases [2]. In clinical trials, these effects were typically mild to moderate and decreased over time as patients adjusted to each dose level. The four-week period at 1mg allows your body to adapt before progressing to higher doses.

To minimise side effects, eat smaller, more frequent meals rather than large portions, avoid high-fat foods that slow digestion further, and stay well-hydrated throughout the day. If nausea persists beyond the first week at 1mg, contact your prescriber—they may recommend remaining at this dose for an additional four weeks before progressing to 1.7mg. Never increase your dose without prescriber approval, as this increases the risk of severe gastrointestinal distress.

When to Contact Your Prescriber

Seek immediate medical attention if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing fluid intake, signs of pancreatitis (severe upper abdominal pain radiating to the back), or allergic reactions including rash, swelling, or difficulty breathing [3]. These serious adverse events are rare but require prompt evaluation. Your UK prescriber can be contacted through Cured Pharmacy at (+44) 116 4646009 for non-emergency concerns about tolerability or dose progression.

Wegovy 1mg Price UK: Understanding Your Investment

Weight management medication represents a significant investment in your health, particularly when NHS prescription pathways have limited availability and strict eligibility criteria. Private prescriptions through UK-registered online pharmacies offer faster access with flexible eligibility based on clinical appropriateness rather than postcode-dependent formulary restrictions.

At Cured Pharmacy, Wegovy is available from £79.00, with transparent pricing displayed before consultation. This includes the medication, prescriber review, dispensing by our GPhC-registered pharmacy team, and discreet delivery to your address. There are no hidden consultation fees or membership charges—the price you see reflects the complete service. As you progress through dose levels towards the 2.4mg maintenance dose, your prescriber will discuss the full treatment pathway and associated costs, ensuring you can plan your weight management programme effectively.

Scientific References

1. Novo Nordisk. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Medicines and Healthcare products Regulatory Agency. (2023). Semaglutide (Wegovy): Important safety information for healthcare professionals. GOV.UK. https://www.gov.uk/drug-safety-update/semaglutide-wegovy
4. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is indicated for weight management in adults with a BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities, alongside a reduced-calorie diet and increased physical activity. Individual results may vary.